0001437749-20-000323.txt : 20200107 0001437749-20-000323.hdr.sgml : 20200107 20200107200451 ACCESSION NUMBER: 0001437749-20-000323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200107 DATE AS OF CHANGE: 20200107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LIU VIVIAN H CENTRAL INDEX KEY: 0001203467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52991 FILM NUMBER: 20514354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001411879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900814124 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8845 REHCO ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-964-5123 MAIL ADDRESS: STREET 1: 8845 REHCO ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: North Horizon, Inc. DATE OF NAME CHANGE: 20070910 4 1 rdgdoc.xml FORM 4 X0306 4 2020-01-02 0001411879 INNOVUS PHARMACEUTICALS, INC. INNV 0001203467 LIU VIVIAN H 8845 REHCO ROAD SAN DIEGO CA 92121 1 Restricted Stock Units 2020-01-02 4 A 0 10112 0.89 A 2020-01-02 2030-01-02 Common Stock 10112 42902 D Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock. The Reporting Person was granted a Restricted Stock Unit on January 2, 2020 of 10,112 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2020 and was valued on December 31, 2019 in accordance with the approved compensation plan for the non-employee members of the Board of Directors. These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan. /s/ VIVIAN LIU 2020-01-02